Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15–55 years and first-time modelling of antibody responses in mature women: results from an open-label 6–year follow-up study

OBJECTIVE: Evaluation of the long-term HPV-16/18 AS04-adjuvanted vaccine immunogenicity persistence in women. DESIGN: Multicentre, open-label, long-term follow-up (NCT00947115) of a primary phase–III study (NCT00196937). SETTING: Six centres in Germany and Poland. POPULATION: 488 healthy women (aged...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BJOG
Egile Nagusiak: Schwarz, T, Spaczynski, M, Kaufmann, A, Wysocki, J, Gałaj, A, Schulze, K, Suryakiran, P, Thomas, F, Descamps, D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2015
Gaiak:
Gynaecological Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4489326/
https://ncbi.nlm.nih.gov/pubmed/25208608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1471-0528.13070
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak